Literature DB >> 27656493

Vitamin Supplementation as an Adjuvant Treatment for Alzheimer's Disease.

Adnan Bashir Bhatti1, Muhammad Usman2, Farhan Ali3, Siddique Akbar Satti4.   

Abstract

Alzheimer's Disease (AD) is a slowly progressing neurodegenerative disorder representing a major health concern worldwide. This disorder is characterised by progressive dementia and cognitive decline. The pathological hallmarks of AD include the presence of Aβ plaques and tau neurofibrils. Research has shown that oxidative stress represents a major risk factor associated with AD pathology. Accumulation of Aβ plaques and relative lack of antioxidant defence mechanisms, including cellular antioxidant enzymes and dietary antioxidants like vitamins, assist in the exacerbation of oxidative stress. Reactive Oxygen Species (ROS) produced as the result of oxidative stress, that increase structural and functional abnormalities in brain neurons, which then manifests as dementia and decline in cognition. Data from numerous epidemiological studies suggests that nutrition is one of the most important yet modifiable risk factors for AD. Since oxidative stress contributes a great deal in the development and progression of AD, anything that could attenuate oxidative stress would help in decreasing the prevalence and incidence of AD. There is increasing evidence that supports the use of different antioxidant as an adjuvant treatment for AD. Vitamins are one such antioxidant that can be used as an adjuvant in AD treatment. This paper will focus on the evidence, based on current literature, linking the use of vitamin supplementations as an adjuvant treatment for AD.

Entities:  

Keywords:  Antioxidant vitamins; Oxidative stress; Reactive oxygen species

Year:  2016        PMID: 27656493      PMCID: PMC5028542          DOI: 10.7860/JCDR/2016/20273.8261

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  73 in total

1.  Vitamin B12 levels in Alzheimer's disease: association with clinical features and cytokine production.

Authors:  Antonis Politis; Paolo Olgiati; Petros Malitas; Diego Albani; Alessandra Signorini; Letizia Polito; Stefania De Mauro; Aikaterini Zisaki; Christina Piperi; Evangelia Stamouli; Antonis Mailis; Sara Batelli; Gianluigi Forloni; Diana De Ronchi; Anastasios Kalofoutis; Ioannis Liappas; Alessandro Serretti
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 2.  Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.

Authors:  David Q Pham; Roda Plakogiannis
Journal:  Ann Pharmacother       Date:  2005-11-15       Impact factor: 3.154

3.  [Familial idiopathic vitamin E deficiency associated with cerebellar atrophy].

Authors:  K Aoki; Y Washimi; N Fujimori; K Maruyama; N Yanagisawa
Journal:  Rinsho Shinkeigaku       Date:  1990-09

Review 4.  Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis.

Authors:  Cedric Annweiler; David J Llewellyn; Olivier Beauchet
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 5.  Redox control of neural function: background, mechanisms, and significance.

Authors:  Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2006 Nov-Dec       Impact factor: 8.401

Review 6.  Vitamin A and Alzheimer's disease.

Authors:  Kenjiro Ono; Masahito Yamada
Journal:  Geriatr Gerontol Int       Date:  2011-12-23       Impact factor: 2.730

7.  Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change.

Authors:  Martha Clare Morris; Denis A Evans; Christine C Tangney; Julia L Bienias; Robert S Wilson; Neelum T Aggarwal; Paul A Scherr
Journal:  Am J Clin Nutr       Date:  2005-02       Impact factor: 7.045

8.  Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.

Authors:  Peter P Zandi; James C Anthony; Ara S Khachaturian; Stephanie V Stone; Deborah Gustafson; JoAnn T Tschanz; Maria C Norton; Kathleen A Welsh-Bohmer; John C S Breitner
Journal:  Arch Neurol       Date:  2004-01

9.  Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging.

Authors:  Joan Lindsay; Danielle Laurin; René Verreault; Réjean Hébert; Barbara Helliwell; Gerry B Hill; Ian McDowell
Journal:  Am J Epidemiol       Date:  2002-09-01       Impact factor: 4.897

10.  Effects of α-tocopherol and ascorbic acid in the severity and management of traumatic brain injury in albino rats.

Authors:  Gaafar M Ishaq; Yusuf Saidu; Lawal S Bilbis; Suleiman A Muhammad; Nasir Jinjir; Bello B Shehu
Journal:  J Neurosci Rural Pract       Date:  2013-07
View more
  10 in total

1.  Dietary Vitamin E Status Dictates Oxidative Stress Outcomes by Modulating Effects of Fish Oil Supplementation in Alzheimer Disease Model APPswe/PS1dE9 Mice.

Authors:  Shengqi Dong; Xiaochen Huang; Jie Zhen; Nicholas Van Halm-Lutterodt; JiaJia Wang; Cui Zhou; Linhong Yuan
Journal:  Mol Neurobiol       Date:  2018-04-14       Impact factor: 5.590

Review 2.  Complementary and Integrative Medicine for Neurologic Conditions.

Authors:  Rebecca Erwin Wells; Vanessa Baute; Helané Wahbeh
Journal:  Med Clin North Am       Date:  2017-06-23       Impact factor: 5.456

Review 3.  Natural remedies for Alzheimer's disease: A systematic review of randomized controlled trials.

Authors:  Saara Ahmad; Saad Bilal Ahmed; Asra Khan; Muhammad Wasim; Saiqa Tabassum; Saida Haider; Fatima Ahmed; Zehra Batool; Saima Khaliq; Hamna Rafiq; Prashant Tikmani; Anwar-Ul-Hassan Gilani
Journal:  Metab Brain Dis       Date:  2022-08-12       Impact factor: 3.655

Review 4.  Metabolism-Centric Overview of the Pathogenesis of Alzheimer's Disease.

Authors:  Somang Kang; Yong Ho Lee; Jong Eun Lee
Journal:  Yonsei Med J       Date:  2017-05       Impact factor: 2.759

Review 5.  Advances in Multi-Functional Ligands and the Need for Metal-Related Pharmacology for the Management of Alzheimer Disease.

Authors:  Abha Sharma; Vidhu Pachauri; S J S Flora
Journal:  Front Pharmacol       Date:  2018-11-15       Impact factor: 5.810

6.  Diminished circulating retinol and elevated α-TOH/retinol ratio predict an increased risk of cognitive decline in aging Chinese adults, especially in subjects with ApoE2 or ApoE4 genotype.

Authors:  Xiaochen Huang; Huiqiang Zhang; Jie Zhen; Shengqi Dong; Yujie Guo; Nicholas Van Halm-Lutterodt; Linhong Yuan
Journal:  Aging (Albany NY)       Date:  2018-12-20       Impact factor: 5.682

Review 7.  Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease.

Authors:  Shampa Ghosh; Shantanu Durgvanshi; Shreya Agarwal; Manchala Raghunath; Jitendra Kumar Sinha
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

8.  Modified Low-Temperature Extraction Method for Isolation of Bletilla striata Polysaccharide as Antioxidant for the Prevention of Alzheimer's Disease.

Authors:  Yi-Wen Lin; Chih-Hsiang Fang; Ya-Jyun Liang; Hong-Hsiang Liao; Feng-Huei Lin
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

Review 9.  Mitochondria-Targeted Therapeutics for Alzheimer's Disease: The Good, the Bad, the Potential.

Authors:  Yashi Mi; Guoyuan Qi; Roberta Diaz Brinton; Fei Yin
Journal:  Antioxid Redox Signal       Date:  2020-04-21       Impact factor: 8.401

Review 10.  Diet Associated with Inflammation and Alzheimer's Disease.

Authors:  Maryam Vasefi; Mackenzie Hudson; Ehsan Ghaboolian-Zare
Journal:  J Alzheimers Dis Rep       Date:  2019-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.